[go: up one dir, main page]

PE20061303A1 - Composicion farmaceutica que comprende oxaprozina - Google Patents

Composicion farmaceutica que comprende oxaprozina

Info

Publication number
PE20061303A1
PE20061303A1 PE2006000350A PE2006000350A PE20061303A1 PE 20061303 A1 PE20061303 A1 PE 20061303A1 PE 2006000350 A PE2006000350 A PE 2006000350A PE 2006000350 A PE2006000350 A PE 2006000350A PE 20061303 A1 PE20061303 A1 PE 20061303A1
Authority
PE
Peru
Prior art keywords
alkyl
acid
composition including
diphenyltiazol
pharmaceutical composition
Prior art date
Application number
PE2006000350A
Other languages
English (en)
Inventor
Morten Sloth Weiner
Original Assignee
Astion Dev As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astion Dev As filed Critical Astion Dev As
Publication of PE20061303A1 publication Critical patent/PE20061303A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE REFIERE AL USO DE OXAPROZINA O DE UN COMPUESTO ESTRECHAMENTE RELACIONADO DE FORMULA I DONDE R SE SELECCIONA ENTRE ALQUILO C1-C3, ALQUENILO C2-C3 Y ALQUINILO C2-C3; R ES DERIVADO DE LA SUSTITUCION DE H CON CN, HALOGENO, OH, NH2 Y NO2; R1 Y R2 SON H, ALQUILO C1-C6, ALQUENILO C2-C6, ALQUINILO C2-C6, ALCOXILO C1-C6, ENTRE OTROS; R3 Y R4 SON H, ALQUILO C1-C6, ALQUENILO C2-C6; R5 ES OH, OR6, NH2, NHR', ENTRE OTROS; R6 ES ALQUILO C1-C6, ARILO, NH2, NHR', ENTRE OTROS; R' Y R'' SON ALQUILO C1-C6, ALQUENILO C2-C6. SON COMPUESTOS PREFERIDOS ACIDO 4,5-DIFENILTIAZOL-2-IL-PROPIONICO, ACIDO 4,5-DIFENILTIAZOL-2-IL-ACRILICO, ACIDO 4,5-DIFENILTIAZOL-2-IL-ACETICO, ACIDO 4,5-DIFENILTIAZOL-2-IL-PROPIONICO, ACIDO 4,5-DI-(4'-CLOROFENILO)-OXAZOL-2-IL-PROPIONICO, ACIDO 4-(4'-BROMOFENIL)-5-FENILOXAZOL-2-IL-PROPIONICO, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION DERMATOLOGICA QUE COMPRENDE OXAPROZINA. LA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE ENFERMEDADES DERMATOLOGICAS Y PRURITO
PE2006000350A 2005-03-30 2006-03-30 Composicion farmaceutica que comprende oxaprozina PE20061303A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200500437 2005-03-30
DKPA200500438 2005-03-30
DKPA200500948 2005-06-27
DKPA200500949 2005-06-27

Publications (1)

Publication Number Publication Date
PE20061303A1 true PE20061303A1 (es) 2006-12-07

Family

ID=38218953

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000350A PE20061303A1 (es) 2005-03-30 2006-03-30 Composicion farmaceutica que comprende oxaprozina

Country Status (5)

Country Link
US (3) US20060222671A1 (es)
AR (1) AR054336A1 (es)
PE (1) PE20061303A1 (es)
TW (1) TW200722087A (es)
UY (1) UY29449A1 (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8846039B2 (en) * 2002-04-26 2014-09-30 Asan Laboratories Company (Cayman), Limited Method for ameliorating pruritus
US6809118B2 (en) * 2002-07-25 2004-10-26 Yih-Lin Chung Methods for therapy of radiation cutaneous syndrome
US20060275370A1 (en) * 2002-07-25 2006-12-07 Yih-Lin Chung Method and compositions for treatment of epithelial damage
US8946295B2 (en) * 2002-07-25 2015-02-03 Sunny Pharmtech Inc. Histone hyperacetylating agents for promoting wound healing and preventing scar formation
US8163764B2 (en) * 2002-04-26 2012-04-24 Asan Laboratories Company (Cayman) Limited Skincare methods
HUE026021T2 (en) 2005-02-16 2016-05-30 Anacor Pharmaceuticals Inc Biocidal boron phthalide (boronophthalide) compounds
KR20080110984A (ko) 2005-12-30 2008-12-22 아나코르 파마슈티칼스 인코포레이티드 보론함유 소분자
CA2933994A1 (en) * 2006-02-16 2007-08-23 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
US20080107743A1 (en) * 2006-11-02 2008-05-08 Akpharma Inc. Composition and method for enhancing skin cell growth, proliferation and repair
US7622614B2 (en) * 2007-03-20 2009-11-24 Allylix, Inc. Methods for production of 5-epi-β-vetivone, 2-isopropyl-6,10-dimethyl-spiro [4.5]deca-2,6-dien-8-one, and 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-1,6-dien-8-one
US8124811B2 (en) * 2007-03-20 2012-02-28 Allylix, Inc. Fragrance and methods for production of 5-epi-β-vetivone, 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-2,6-dien-8-one, and 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-1,6-dien-8-one
WO2009049172A1 (en) * 2007-10-10 2009-04-16 Therametics, Llc Methods and compositions for treating dermatological diseases and conditions
US9616006B2 (en) 2007-10-10 2017-04-11 DermaMedics, LLC Methods and compositions for treating dermatological diseases and conditions
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
JP2015178508A (ja) * 2008-01-09 2015-10-08 アナコール ファーマシューティカルズ，インコーポレイテッド 抗炎症剤としてのホウ素含有小分子
JP5745279B2 (ja) * 2008-01-09 2015-07-08 アナコール ファーマシューティカルズ，インコーポレイテッド 抗炎症剤としてのホウ素含有小分子
DE102008006393A1 (de) * 2008-01-28 2009-07-30 Beiersdorf Ag Verwendung von Lipidkomponenten gegen Pollenallergien
EP2187893A4 (en) * 2008-03-06 2012-02-22 Anacor Pharmaceuticals Inc SMALL BORON-CONTAINING MOLECULES AS ANTI-INFLAMMATORY AGENTS
MX2010009765A (es) 2008-03-06 2013-07-12 Anacor Pharmaceuticals Inc Moleculas pequeñas que contienen boro como agentes anti-inflamatorios.
US20100256092A1 (en) * 2008-05-12 2010-10-07 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US8461336B2 (en) 2008-09-04 2013-06-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
EP2348863A4 (en) * 2008-09-04 2012-03-07 Anacor Pharmaceuticals Inc BORN SMALL MOLECULES
US9493489B2 (en) * 2008-10-15 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
SG172040A1 (en) * 2008-12-17 2011-07-28 Anacor Pharmaceuticals Inc Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol
EP2405904B1 (en) * 2009-03-13 2018-12-05 DBV Technologies Method of treating eczema
JP2013500974A (ja) * 2009-07-28 2013-01-10 アナコール ファーマシューティカルズ，インコーポレイテッド 三置換ホウ素含有分子
AP4039A (en) * 2009-08-14 2017-02-28 Daitao Chen Boron-containing small molecules as antiprotozoal agents
US20110207701A1 (en) * 2009-08-19 2011-08-25 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
US20110124597A1 (en) * 2009-09-25 2011-05-26 Anacor Pharmaceuticals, Inc. Boron containing small molecules
US9346834B2 (en) 2009-10-20 2016-05-24 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
US20110212918A1 (en) * 2009-11-11 2011-09-01 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2011094450A1 (en) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Boron-containing small molecules
US9551710B2 (en) 2010-02-09 2017-01-24 Drexel University Signaling molecule involved in ultraviolet damage to skin
US8623911B2 (en) 2010-03-19 2014-01-07 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agent
IT1406067B1 (it) * 2010-07-14 2014-02-06 Torino Politecnico Composizioni eudermiche.
DK3251678T3 (da) 2010-09-07 2021-11-22 Anacor Pharmaceuticals Inc Benzoxaborolderivater til behandling af bakterieinfektioner
CA2991569A1 (en) * 2015-07-08 2017-01-12 Elliptical Therapeutics, Llc Improved topical ketoprofen formulations
US11447506B2 (en) 2016-05-09 2022-09-20 Anacor Pharmaceuticals, Inc. Crystal forms of crisaborole in free form and preparation method and use thereof
EP3315488A1 (en) * 2016-10-28 2018-05-02 Elé Corporation Amino acid based amphoteric surfactant
EP3615032A4 (en) * 2017-04-28 2020-12-23 Asana BioSciences, LLC FORMULATIONS, PROCEDURES, KITS AND DOSING FORMS FOR TREATMENT OF ATOPIC DERMATITIS AND IMPROVED STABILITY OF AN ACTIVE INGREDIENT
KR20200025244A (ko) * 2018-08-29 2020-03-10 연세대학교 산학협력단 푸니칼라진을 포함하는 소양증 예방, 개선 또는 치료용 조성물

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE32084B1 (en) * 1967-06-07 1973-04-04 Wyeth John & Brother Ltd Thiazole derivatives
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
US4190584A (en) * 1976-08-13 1980-02-26 John Wyeth & Brother Limited Process for preparing oxazoles
IE52909B1 (en) * 1981-04-28 1988-04-13 Wyeth John & Brother Ltd Oxazole derivatives
US4659728A (en) * 1985-02-25 1987-04-21 American Home Products Corporation Hydroxy substituted 4,5-diphenyl-2-oxazole propanoic acid
US4773023A (en) * 1985-04-12 1988-09-20 Giardina Joseph J Apparatus for measuring the rate of heat dissipation
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
JPS63309077A (ja) * 1987-06-11 1988-12-16 Seikosha Co Ltd ビデオプリンタ
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
CA2058975C (en) * 1990-10-30 2000-06-06 Shuichi Kasai Antiinflammatory gel preparation
US6017900A (en) * 1991-07-03 2000-01-25 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and nsaids
SK43294A3 (en) * 1991-10-16 1995-01-12 Richardson Vicks Inc Agent improving the penetration of treatments at surface application
EG20380A (en) * 1991-10-16 1999-02-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
JP3567990B2 (ja) * 1992-07-28 2004-09-22 ザ、プロクター、エンド、ギャンブル、カンパニー 架橋陽イオン重合体とアルコキシ化エーテルとを含有する局所用途用医薬組成物
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US6090834A (en) * 1993-05-21 2000-07-18 G.D. Searle & Co. Substituted oxazoles for the treatment of inflammation
US6309630B1 (en) * 1994-05-24 2001-10-30 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic suspensions
DE69519055T2 (de) * 1994-06-22 2001-05-31 Canon K.K., Tokio/Tokyo Träger für die Elektrophotographie, Zwei-Komponenten-Entwickler und Verfahren zur Bildherstellung
US5948416A (en) * 1995-06-29 1999-09-07 The Procter & Gamble Company Stable topical compositions
WO1997044022A1 (en) * 1996-05-20 1997-11-27 G.D. Searle & Co. Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
CN1180709A (zh) * 1996-10-21 1998-05-06 湖南医科大学 遗传多发性外生骨疣家族的新多核苷酸和多肽基因
FR2765338B1 (fr) * 1997-06-25 1999-07-23 Inst Francais Du Petrole Dispositif de prelevement et/ou d'injection d'un echantillon de fluide permettant de conserver l'equilibre chimique et/ou thermodynamique
US6432963B1 (en) * 1997-12-15 2002-08-13 Yamanouchi Pharmaceutical Co., Ltd. Pyrimidine-5-carboxamide derivatives
US5984416A (en) * 1998-04-30 1999-11-16 Calvin College Adjustable armrest
US6096896A (en) * 1998-10-15 2000-08-01 Farchemia S.R.L. Process for the preparation of 4.5-diphenyloxazole-2-propanoic acid
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6284802B1 (en) * 1999-04-19 2001-09-04 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue
US20030138399A1 (en) * 1999-05-14 2003-07-24 Anton Peter A. Anti-inflammatory therapy for inflammatory mediated infection
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US6645520B2 (en) * 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
US20020127256A1 (en) * 2001-03-01 2002-09-12 Howard Murad Compositions and methods for treating dermatological disorders
AP2003002922A0 (en) * 2001-05-31 2003-12-31 Pharmacia Corp Skin-permeable selective cyclooxygenase-2 inhibitor composition.
JPWO2003024484A1 (ja) * 2001-09-14 2004-12-24 小野薬品工業株式会社 掻痒症治療剤
CA2472459A1 (en) * 2002-01-10 2003-07-24 Kong Teck Chong Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections
TW200403072A (en) * 2002-01-23 2004-03-01 Upjohn Co Combination therapy for the treatment of bacterial infections
US20030232091A1 (en) * 2002-06-17 2003-12-18 Adi Shefer Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
SI1587506T1 (sl) * 2002-12-18 2009-04-30 Algorx 101 Interchange Plaza S Zdravljenje s kapsaicinom
WO2004056349A2 (en) * 2002-12-19 2004-07-08 Pharmacia Corporation Methods and compositions for the treatment of herpes virus infections using cyclooxygenase-2 selective inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents
CA2521429A1 (en) * 2003-04-04 2004-10-21 Unigen Pharmaceuticals, Inc. Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care
US6852713B2 (en) * 2003-04-16 2005-02-08 Adolor Corporation Lactam derivatives and methods of their use

Also Published As

Publication number Publication date
TW200722087A (en) 2007-06-16
UY29449A1 (es) 2006-10-02
AR054336A1 (es) 2007-06-20
US20060251689A1 (en) 2006-11-09
US20060229347A1 (en) 2006-10-12
US20060222671A1 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
PE20061303A1 (es) Composicion farmaceutica que comprende oxaprozina
PE20191541A1 (es) Composiciones y metodos para inhibir la accion de la arginasa
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
PE20061490A1 (es) Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1
PE20090601A1 (es) Derivados de piridin-il-oxi-piridinas como inhibidores de alk5
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
UY28314A1 (es) Preparacion y uso de derivados de alquilarilo para el tratamiento de la obesidad
BRPI0608732A2 (pt) composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto
ATE368031T1 (de) Neue gamma secretase inhibitoren
ECSP105253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
UY30025A1 (es) Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones.
PE20120058A1 (es) Derivados de imidazopirazina como inhibidores de syk
PE20081754A1 (es) Complejos cristalinos de compuestos organicos activos para uso agricola
PE20060525A1 (es) Compuestos heterociclicos como inhibidores de cetp
UY28014A1 (es) Compuestos quimicos
PE20090417A1 (es) Compuestos de piperazina con accion herbicida
AR054129A1 (es) Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7
DK1200426T3 (da) Substituerede thien-3-yl-sulfonylamino(thio)carbonyl-tiazolin(thi)oner
BRPI0518459A2 (pt) composto ou um sal farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, uso de um composto, e, processo para preparar o composto ou um sal farmaceuticamente aceitÁvel do mesmo
TW200510405A (en) Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
BRPI0418181A (pt) emprego de 2-aminotetralinas substituìdas para prevenção do tratamento de morbus parkinson
ECSP078062A (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
PE20080364A1 (es) Acido bifenilcarboxilicos substituidos y sus derivados como moduladores de la actividad de la gamma-secretasa
ATE435223T1 (de) Pyrimidin-, chinazolin-, pteridin- und triazinderivate

Legal Events

Date Code Title Description
FC Refusal